<Disease><Name>ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II (IGHD2)</Name><Synonym>IGHD II</Synonym><OMIM><Number>173100</Number><URL>http://omim.org/entry/173100</URL></OMIM><Orphanet><Number>231679</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=231679</URL></Orphanet><Protein><Number>Somatotropin</Number><URL>http://www.uniprot.org/uniprot/P01241</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>17q23.3</Gene><ICD>E23.0</ICD><Summary>rare;autosomal dominant;mutations in the gene for growth hormone (GH1)</Summary><Symptoms><symtomp><id>3245</id><symptom>dwarfism</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>4611</id><title>Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II</title><author>Miletta MC,</author><journal>Biochem Pharmacol</journal><year>2017</year><book /><volume>124</volume><number>0</number><pages>1-9</pages><co_aut>Flueck CE2, Mullis PE</co_aut></literature><literature><id>4612</id><title>Autosomal Dominant Growth Hormone Deficiency (Type II)</title><author>Alatzoglou KS,</author><journal>Pediatr Endocrinol Rev</journal><year>2015</year><book /><volume>12</volume><number>4</number><pages>347-355</pages><co_aut>Kular D, Dattani MT</co_aut></literature><literature><id>4613</id><title>Isolated growth hormone deficiency type 2: from gene to therapy</title><author>Miletta MC,</author><journal>Endocr Dev</journal><year>2012</year><book /><volume>23</volume><number>0</number><pages>109-120</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>